Verkauf durch Sack Fachmedien

Parak / Feliu

Colloids for Nanobiotechnology

Medium: Buch
ISBN: 978-0-08-102828-5
Verlag: Elsevier Science & Technology
Erscheinungstermin: 29.04.2020
Lieferfrist: bis zu 10 Tage
Colloids for Nanobiotechnology: Synthesis, Characterization and Potential Applications, Volume 17, offers a range of perspectives on emerging nano-inspired colloidal applications. With an emphasis on biomedical and environmental opportunities and challenges, the book outlines how nanotechnology is being used to increase the uses and impact of colloid science. Nanotechnology offers new horizons for colloidal research and synthesis routes that allow for the production of highly reproducible and defined materials. This book presents new characterization methods and a fundamental understanding of basic physicochemical, physical and chemical properties.

Produkteigenschaften


  • Artikelnummer: 9780081028285
  • Medium: Buch
  • ISBN: 978-0-08-102828-5
  • Verlag: Elsevier Science & Technology
  • Erscheinungstermin: 29.04.2020
  • Sprache(n): Englisch
  • Auflage: Erscheinungsjahr 2020
  • Produktform: Kartoniert
  • Gewicht: 423 g
  • Seiten: 398
  • Format (B x H x T): 191 x 235 x 17 mm
  • Ausgabetyp: Kein, Unbekannt

Autoren/Hrsg.

Autoren

Parak, Wolfgang

Herausgeber

Parak, Wolfgang

Wolfgang J. Parak is Professor at the Department of Physics and Chemistry at Hamburg University, Germany. He is an advisory board member of the Elsevier journal, Journal of Colloid and Interface Science.

Feliu, Neus

Neus Feliu is a Research Fellow at the Department of Physics and Chemistry at Hamburg University, Germany, and the Department of Laboratory Medicine (LABMED), Karolinska Institutet, Sweden. Her research is focused on engineered nanomaterials for biomedical applications.

1. Colloids for Nanobiotechnology - An Introductio2. Surface-enhanced Raman scattering (SERS) sensing of nucleic acids3. Energy transfer with nanoparticles for in vitro diagnostic4. Nanoparticles for imaging application5. Colloidal nanoparticles as pharmaceutical agent6. Fluorescent nanoparticles for sensin7. Two-dimensional nanoparticles for the delivery of anticancer drugs and cancer therapy8. Engineered polymeric nanovehicles for drug deliver9. Polymer-based nanoparticles for biomedical applications10. Targeted delivery of nanoparticles11. Nanoparticles for immunotherap12. Targeted hyperthermia with plasmonic nanoparticles13. Current challenges and coming opportunities in nanoparticle risk assessment